Trial Profile
Open clinical trial to evaluate safety, tolerability, and efficacy of Dexdor for sedation in paediatric patients in intensive care settings. Multi-centre trial in Russia for marketing registration of Dexdor
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jan 2019
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Registrational; Therapeutic Use
- Acronyms PEDRUX
- Sponsors Orion Pharma
- 22 Jan 2019 Status changed from not stated to completed.
- 15 Oct 2018 New trial record